1. Acquired perforating dermatosis associated with sorafenib therapy. (11th September 2014) Authors: Severino‐Freire, M.; Sibaud, V.; Tournier, E.; Pauwels, C.; Christol, C.; Lamant, L.; Hautier‐Mazeereuw, J.; Peron, J.‐M.; Paul, C.; Bulai Livideanu, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 2(2016:Feb.) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study. (3rd June 2016) Authors: Guinard, E.; Bulai Livideanu, C.; Barthélémy, H.; Viguier, M.; Reguiai, Z.; Richard, M.A.; Jullien, D.; Beneton, N.; Bara, C.; Vabres, P.; Grandvuillemin, A.; Marguery, M.C.; Amelot, F.; Konstantinou, M.P.; Bagheri, H.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 8(2016:Aug.) Page Start: 1336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis. Issue 1 (January 2016) Authors: Bulai Livideanu, C.; Apoil, P. A.; Lepage, B.; Eischen, M.; Laurent, C.; Laharrague, P.; Lamant, L.; Tournier, E.; Tavitian, S.; Pouplard, C.; Recher, C.; Laroche, M.; Mailhol, C.; Dubreuil, P.; Hermine, O.; Blancher, A.; Paul, C. Journal: Clinical & experimental allergy Issue: Volume 46:Issue 1(2016:Jan.) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus. (1st July 2016) Authors: Boulard, C.; Duvert Lehembre, S.; Picard‐Dahan, C.; Kern, J.S.; Zambruno, G.; Feliciani, C.; Marinovic, B.; Vabres, P.; Borradori, L.; Prost‐Squarcioni, C.; Labeille, B.; Richard, M.A.; Ingen‐Housz‐Oro, S.; Houivet, E.; Werth, V.P.; Murrell, D.F.; Hertl, M.; Benichou, J.; Joly, P.; Hofmann, S. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Changes in interleukin‐17A, macrophage‐derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO‐ABLE study. (6th December 2017) Authors: Røpke, M.; Bulai Livideanu, C.; Kaldate, R.; Snel, A.; Paul, C. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: e33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Changes in interleukin‐17A, macrophage‐derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO‐ABLE study. (1st January 2018) Authors: Røpke, M.; Bulai Livideanu, C.; Kaldate, R.; Snel, A.; Paul, C. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: e33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cutaneous mastocytosis in adults with a serum tryptase level < 20 ng mL–1: why we should investigate further. (1st August 2021) Authors: Jendoubi, F.; Shourick, J.; Negretto, M.; Laurent, C.; Apoil, P.A.; Evrard, S.; Mansat‐De Mas, V.; Severino‐Freire, M.; Mailhol, C.; Degboé, Y.; Dubreuil, P.; Hermine, O.; Paul, C.; Bulai Livideanu, C. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cutaneous mastocytosis in adults with a serum tryptase level < 20 ng mL–1: why we should investigate further. (2nd June 2021) Authors: Jendoubi, F.; Shourick, J.; Negretto, M.; Laurent, C.; Apoil, P.A.; Evrard, S.; Mansat‐De Mas, V.; Severino‐Freire, M.; Mailhol, C.; Degboé, Y.; Dubreuil, P.; Hermine, O.; Paul, C.; Bulai Livideanu, C. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of ixekizumab in patients with resistance or incomplete response to secukinumab. (29th April 2019) Authors: Hegazy, S.; Konstantinou, M.P.; Bulai Livideanu, C.; Tauber, M.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 9(2019) Page Start: e338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of ustekinumab in palmoplantar pustulosis. (8th January 2018) Authors: Hegazy, S.; konstantinou, M.P.; Bulai Livideanu, C.; Tauber, M.; Uthurriague, C.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 5(2018) Page Start: e204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗